Few studies of PAI-1 have been reported in dogs to date but a previous study using a different assay, observed increased PAI-1 activity in hyperlipidemic dogs with hyperadrenocorticism and diabetes mellitus (97). Here, SERPINE1 is linked to diabetes mellitus.